Niagen bioscience inc NAGE.US Value Analysis
US StockHealth Care
(Powered by 
)
)NAGE Value Score
3
24
15
Good Growth
- AI analysis rates NAGE with a higher value score of 4.
- It is mainly due to stable revenue growth, along with adequate safety shown in the balance sheet.
- Over the past 3 months, NAGE has maintained a consecutive value rating of 4.0, close to the rating of 4.1 over the past 3 years, indicating stable enterprise value.
- Compared to all stocks in the Health Care sector, NAGE has a higher value rating.
NAGE Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/03/06 (Weekly Update)
NAGE Financial Forecast
Unit : USD
Update to 2025/5/4 (Quarterly Update)
NAGE Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | 0.03 | - | 50% | 29.13M | - | 8.8% | 7.3% |
Update to 2025/5/8 (Quarterly Update)
NAGE Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
NAGE Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of NAGE from 2008/06 till Now
- -50.24%
- Cumulative Return
- -4.28%
- Annual Return
- 50.06%
- Volatility
- -0.09
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from June, 2008 to May, 2025. (Total Trades: 3)
| NAGE | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | 33% | 44% | 53% |
| Avg Return | -16.1% | 63.1% | 72.3% |
| Avg Profit | 0.2% | 198.4% | 166.4% |
| Avg Loss | -24.3% | -44.8% | -34.6% |
| Avg Risk-Reward Ratio | 1% | 442.5% | 480.4% |
Update to 2025/5/8 (Daily Update)